Anesthetic Implications for Pheochromocytoma Removal
The most critical anesthetic implication for pheochromocytoma removal is mandatory preoperative alpha-adrenergic blockade for 10-14 days before surgery to prevent potentially life-threatening hypertensive crises and arrhythmias during tumor manipulation. 1, 2
Preoperative Management
Alpha-Adrenergic Blockade
- Preoperative alpha-adrenergic blockade must be initiated at least 7-14 days before surgery with gradually increasing dosages 1, 2
- Blood pressure targets: <130/80 mmHg supine and systolic blood pressure >90 mmHg in upright position 1, 2
- Two main options for alpha blockade:
- The PRESCRIPT trial showed phenoxybenzamine may provide less intraoperative hemodynamic instability compared to doxazosin, though both are effective 1, 4
Beta-Adrenergic Blockade
- Beta-blockers should ONLY be added AFTER adequate alpha blockade to control tachyarrhythmias 1, 2
- Never use beta-blockers alone as monotherapy, as this can precipitate hypertensive crisis due to unopposed alpha-adrenergic stimulation 5
- Preferably use cardioselective beta-1 blockers when needed 1
Additional Preoperative Measures
- High-sodium diet and administration of 1-2 liters of saline 24 hours prior to surgery 1, 2
- Use of compressive stockings to reduce risk of orthostatic and postoperative hypotension 1, 2
- Calcium channel blockers may be used as adjuncts to alpha-blockers for refractory hypertension 1, 2
- Metyrosine (alpha-methyl-p-tyrosine), a catecholamine synthesis inhibitor, can be used as an add-on medication where available to further reduce catecholamine production 1, 6
Intraoperative Management
Hemodynamic Management
- Hypertension during surgery may be treated with:
- Tachycardia can be treated with intravenous beta-blockers such as esmolol 2, 5
- Patients who receive adequate preoperative alpha blockade (particularly higher doses of phenoxybenzamine) require significantly less intraoperative vasodilators 7
Critical Phases
- Most significant hemodynamic instability occurs during:
- Induction of anesthesia
- Tumor manipulation
- Immediately after tumor removal (risk of hypotension) 2
- Careful monitoring of blood pressure and heart rate is essential throughout the procedure 2
Surgical Approach Considerations
- Laparoscopic adrenalectomy is preferred for most pheochromocytomas, showing better intraoperative hemodynamic stability compared to open surgery 2
- Open surgery should be considered for tumors with high suspicion of malignancy, large size (>6 cm), or local invasion 2
Postoperative Management
Immediate Postoperative Care
- Aggressive treatment of postoperative hypotension is essential due to sudden decrease in catecholamine levels 8
- Close monitoring of blood glucose levels is crucial as hypoglycemia commonly occurs after reduction of catecholamine levels 8
- For bilateral adrenalectomy, high-dose hydrocortisone (150 mg/day) should be administered during the immediate postoperative period 8
Monitoring
- Postoperative biochemical testing should be performed 2-8 weeks after surgery to confirm complete resection 1, 8
- Imaging should be done at 3-6 months postoperatively 1, 8
Special Considerations and Pitfalls
Potential Complications
- Inadequate preoperative alpha blockade can lead to severe hypertensive crises during tumor manipulation 1, 6
- Excessive alpha blockade can cause significant postoperative hypotension requiring vasopressors 4
- Premature beta blockade (before adequate alpha blockade) can precipitate hypertensive crisis 5
- Patients with exclusively dopamine-producing pheochromocytomas (indicated by isolated elevation of plasma methoxytyramine) do not require preoperative alpha blockade 1
Comprehensive Evaluation
- All patients with adrenal masses should undergo comprehensive hormonal evaluation, including testing for both catecholamine excess and other hormone abnormalities 9
- Never perform adrenal biopsy without excluding pheochromocytoma first, as this can trigger life-threatening hypertensive crisis 9
By following these guidelines for preoperative preparation and intraoperative management, the anesthetic risks associated with pheochromocytoma removal can be significantly minimized, improving patient outcomes and reducing perioperative morbidity and mortality.